Picture of aap Implantate AG logo

AAQ1 aap Implantate AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: AAP Implantate FY Sales At EUR 9.3 Mln

Jan 21 (Reuters) - AAP IMPLANTATE AG  AAQ1k.DE :
    * FY/2020: SALES OF EUR 9.3 MILLION IN CORONA YEAR IN UPPER
HALF
OF GUIDANCE - DYNAMIC SALES GROWTH IN USA (+41%); SIGNIFICANT
SALES GROWTH AND POSITIVE EBITDA IN TRAUMA BUSINESS PLANNED FOR
FY/2021
    * Q4 SALES 2.4 MILLION EUR VERSUS 3.1 MILLION EUR YEAR AGO
    * OUTLOOK FY/2021: ASSUMING AN EASING OF COVID-19 SITUATION
FROM
Q2/2021 ONWARDS SIGNIFICANT SALES GROWTH (+29 TO +61%)
    * GUIDANCE 2021 WITH SALES OF EUR 12.0 TO 15.0 MILLION AND
EBITDA
OF EUR -5.5 TO -3.5 MILLION (EUR -2.8 TO -0.8 MILLION EXCLUDING.
RESEARCH AND DEVELOPMENT PROJECT COSTS
    * RESTRUCTURING: FURTHER DOUBLE-DIGIT PERCENTAGE REDUCTION
IN
MANUFACTURING COSTS PLANNED

Source text for Eikon:  ID:nEQ8xSyk9a 
Further company coverage:  AAQ1k.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on aap Implantate AG

See all news